Italian pharmaceutical group A. Menarini successfully recovered the domain glucofix-shop.com in a UDRP proceeding. The respondent registered the domain to host an unauthorized website displaying references to dietary supplements while displaying the Complainant’s trademark and real contact details. Sole panelist Martin Michaus Romero ruled that the domain must be transferred.
Case Snapshot
| Case Number | D2025-4356 |
|---|---|
| Complainant | A. Menarini Industrie Farmaceutiche Riunite S.r.l. |
| Respondent | tian tao |
| Disputed Domain | glucofix-shop.com |
| Threat Tactic | Brand Plus Keyword |
| Decision Date | 2025-12-23 |
| Panelist | Martin Michaus Romero |
| Outcome | Transfer |
| Official Source | https://www.wipo.int/amc/en/domains/search/text.jsp?case=D2025-4356 |
Commercial and Reputational Threats of Trademark-Infringing Portals and Corporate Impersonation
The registration of domains combining established pharmaceutical trademarks with transactional suffixes, such as ‘glucofix-shop.com’, poses an immediate threat of commercial diversion. By targeting A. Menarini’s GLUCOFIX mark, the unauthorized registrant constructed an online portal designed to mimic an authorized retail outlet. This site displayed references to dietary supplements under the Complainant’s trademark, directly intercepting and confusing internet users who were searching for official pharmaceutical products. This unauthorized use compromises trademark exclusivity and diverts valuable web traffic to third-party commercial offerings.
Furthermore, the unauthorized site went beyond basic trademark infringement by scraping and displaying A. Menarini’s actual corporate contact details. This tactic of corporate impersonation significantly amplifies reputation and security risks. By presenting genuine contact information alongside the trademark, the website falsely validated its authenticity to consumers. Although the record in this case contains no evidence of active phishing campaigns or successful consumer fraud, the unauthorized publication of corporate metadata creates an environment ripe for credential exploitation and erodes the critical foundation of customer trust.
Panelist Analysis of Confusing Similarity, Legitimate Interests, and Bad Faith
Under the first element of the UDRP, Panelist Martin Michaus Romero assessed whether the disputed domain name, glucofix-shop.com, is identical or confusingly similar to the Complainant’s registered trademarks. The Complainant, A. Menarini Industrie Farmaceutiche Riunite S.r.l., established its rights in the GLUCOFIX mark through registrations dating back to July 26, 2007, including UK00905147285 and EU 005147285. The Panel found that the disputed domain incorporates the GLUCOFIX trademark in its entirety. The addition of the descriptive hyphenated suffix ‘-shop’ does not prevent a finding of confusing similarity, as the trademark remains fully recognizable within the domain structure.
Regarding the second element, the Panel evaluated whether the Respondent, tian tao, possessed any rights or legitimate interests in the disputed domain. The Complainant confirmed that it had not authorized, licensed, or otherwise consented to the Respondent’s use of the trademark. Crucially, the disputed domain resolved to a website that displayed the GLUCOFIX mark alongside the Complainant’s actual corporate contact details while presenting references to dietary supplements. The Panel adhered to established UDRP consensus, noting that using a domain name for impersonation and passing off cannot confer rights or legitimate interests upon a respondent.
Under the third element, the legal reasoning focused on registration and use in bad faith. Because the GLUCOFIX trademark was registered in 2007, long before the disputed domain’s registration on June 24, 2025, the Respondent was deemed to have targeted the Complainant’s mark. By replicating the Complainant’s trademark and publishing its real physical contact details on a website displaying dietary supplements, the Respondent intentionally attempted to attract Internet users for commercial gain. This setup created a clear likelihood of confusion with the Complainant’s mark as to the source, sponsorship, affiliation, or endorsement of the resolved website.
From a procedural and strategic perspective, the Respondent’s failure to submit a formal response allowed the Panel to decide the dispute based on the Complainant’s uncontested contentions on the balance of probabilities. Although there was no specific evidence in the record demonstrating that consumers were successfully defrauded, suffered health complications, or that active email phishing campaigns were executed, the unauthorized display of corporate contact details and the passing-off behavior were sufficient to establish bad faith. This outcome underscores that brand owners do not need to prove actual consumer harm or secondary threat vectors to secure a transfer under the Policy when clear impersonation is demonstrated.
Evidentiary Precision and Impersonation Metrics in Corporate Recovery
The strategy deployed by A. Menarini Industrie Farmaceutiche Riunite S.r.l. succeeded because it paired long-held trademark registrations for GLUCOFIX, dating back to 2007, with documented proof of direct corporate impersonation. Rather than relying solely on the structural similarity of the domain name glucofix-shop.com, the Complainant presented concrete evidence that the resolving website displayed its actual corporate contact details alongside unauthorized references to dietary supplements. This specific evidence of passing off effectively blocked any possibility of the respondent, tian tao, establishing rights or legitimate interests. Under WIPO Overview 3.0, section 2.13.1, panels consistently hold that using a domain for impersonation can never confer rights, allowing the Complainant to satisfy the second element of the Policy despite the respondent’s default.
From a business and brand-protection perspective, the case demonstrates how combining a registered trademark with a descriptive keyword like ‘-shop’ fails to escape liability. Panelist Martin Michaus Romero affirmed that adding such a suffix does not prevent a finding of confusing similarity. For intellectual property professionals, this case underscores an immediate action plan: documenting the unauthorized scraping of physical contact information is a highly persuasive strategy to establish bad faith registration and use. Even in the absence of documented consumer fraud or active phishing campaigns, demonstrating that a site is structured to divert web traffic and dilute trademark exclusivity is sufficient to secure a swift transfer order under the UDRP.
Practical Recommendations
- Implement proactive domain monitoring alerts for core pharmaceutical trademarks paired with transactional suffixes like ‘-shop’, ‘-store’, or ‘-dealers’ to identify retail-mimicking registrations immediately after they occur.
- Document instances of corporate identity theft by capturing clear side-by-side visual evidence of scraped corporate physical addresses and contact details displayed on unauthorized sites, using this impersonation evidence to establish a lack of rights and bad faith under WIPO Overview 3.0 Section 2.13.1.
- Secure defensive registrations for primary product brand names combined with common retail keywords to prevent bad actors from registering domains that divert traffic to unauthorized third-party dietary supplements.
- Maintain up-to-date, easily accessible digital records of regional trademark registrations (e.g., UK and EU registrations) to facilitate rapid UDRP filings that can proceed swiftly to a transfer order even in the event of a respondent default.
Frequently Asked Questions (FAQ)
Why was the domain ‘glucofix-shop.com’ considered confusingly similar to A. Menarini’s trademark?
The Panel determined that the domain name is confusingly similar because it incorporates the protected GLUCOFIX trademark in its entirety, merely adding the descriptive suffix ‘-shop’, which does not eliminate the likelihood of confusion.
What evidence proved the respondent lacked rights or legitimate interests in the domain?
The Panel found the Respondent had no rights or interests because A. Menarini never authorized or consented to the use of its trademark. Furthermore, using the domain for impersonation and passing off, specifically by displaying the Complainant’s own contact information and brand name, cannot confer legitimate rights.
How did the Panel establish that the domain was registered and used in bad faith?
Bad faith was confirmed because the Respondent intentionally used the domain to attract internet users for commercial gain by creating a false association with the GLUCOFIX brand, compounded by the unauthorized display of the Complainant’s actual corporate contact details.
What was the tactical outcome for A. Menarini in this UDRP proceeding?
Following the Respondent’s failure to reply to the complaint, the Panel ordered the transfer of ‘glucofix-shop.com’ to A. Menarini, effectively shutting down the impersonation site and preventing further traffic diversion and brand dilution.
Detected an unauthorized ‘Brand + Keyword’ domain?
When third parties register domains using your trademark alongside descriptive terms like ‘-shop’, they often aim to facilitate brand impersonation and traffic diversion. Protect your digital assets by assessing your eligibility for a UDRP transfer.
This case note is for informational purposes only and is not legal advice.
